Jaguar Gene Therapy Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 7

Jaguar Gene Therapy General Information

Description

Developer of gene therapy treatments designed to address severe genetic diseases. The company offers a clinical-stage pipeline targeting neurodevelopmental disorders, Type 1 galactosemia, and Type 1 diabetes, enabling patients and their families to access breakthrough therapies led by a team with firsthand experience in gene therapy development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 150 North Field Drive
  • Suite 300
  • Lake Forest, IL 60045
  • United States
+1 (224)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 150 North Field Drive
  • Suite 300
  • Lake Forest, IL 60045
  • United States
+1 (224)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jaguar Gene Therapy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 29-Mar-2022 Completed Pre-Clinical Trials
2. Early Stage VC (Series B) 13-Apr-2021 Completed Pre-Clinical Trials
1. Seed Round 01-Jan-2019 $41M $41M Completed Pre-Clinical Trials
To view Jaguar Gene Therapy’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Jaguar Gene Therapy Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of gene therapy treatments designed to address severe genetic diseases. The company offers a clinical-stage pi
Drug Discovery
Lake Forest, IL
50 As of 2024

Dallas, TX
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jaguar Gene Therapy Competitors (6)

One of Jaguar Gene Therapy’s 6 competitors is Taysha Gene Therapies, a Formerly VC-backed company based in Dallas, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Taysha Gene Therapies Formerly VC-backed Dallas, TX
ElevateBio Venture Capital-Backed Waltham, MA
Sana Biotechnology Formerly VC-backed Seattle, WA
Spark Therapeutics Formerly VC-backed Philadelphia, PA
Regenxbio Formerly VC-backed Rockville, MD
To view Jaguar Gene Therapy’s complete competitors history, request access »

Jaguar Gene Therapy Patents

Jaguar Gene Therapy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3239342-A1 Gene therapy methods for treatment of diabetes Pending 30-Nov-2021
AU-2022401876-A1 Gene therapy methods for treatment of diabetes Pending 30-Nov-2021
EP-4441233-A1 Gene therapy methods for treatment of diabetes Pending 30-Nov-2021
US-20250064978-A1 Gene therapy methods for treatment of diabetes Pending 30-Nov-2021
CA-3230734-A1 Adeno-associated vectors and virions to treat galactosemia and methods of use and manufacture Pending 01-Sep-2021 A61K48/0033
To view Jaguar Gene Therapy’s complete patent history, request access »

Jaguar Gene Therapy Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jaguar Gene Therapy Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
AIF Venture Capital Minority
Samsung Venture Investment Corporate Venture Capital Minority
T1D Fund Venture Capital Minority
ARCH Venture Partners Venture Capital Minority
Eli Lilly and Company Foundation Limited Partner Minority
You’re viewing 5 of 7 investors. Get the full list »

Jaguar Gene Therapy Acquisitions (1)

Jaguar Gene Therapy’s most recent deal was a Merger/Acquisition with Axovia Therapeutics.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Axovia Therapeutics Merger/Acquisition Drug Discovery
To view Jaguar Gene Therapy’s complete acquisitions history, request access »

Jaguar Gene Therapy FAQs

  • When was Jaguar Gene Therapy founded?

    Jaguar Gene Therapy was founded in 2019.

  • Where is Jaguar Gene Therapy headquartered?

    Jaguar Gene Therapy is headquartered in Lake Forest, IL.

  • What is the size of Jaguar Gene Therapy?

    Jaguar Gene Therapy has 50 total employees.

  • What industry is Jaguar Gene Therapy in?

    Jaguar Gene Therapy’s primary industry is Drug Discovery.

  • Is Jaguar Gene Therapy a private or public company?

    Jaguar Gene Therapy is a Private company.

  • What is Jaguar Gene Therapy’s current revenue?

    The current revenue for Jaguar Gene Therapy is .

  • How much funding has Jaguar Gene Therapy raised over time?

    Jaguar Gene Therapy has raised $180M.

  • Who are Jaguar Gene Therapy’s investors?

    AIF, Samsung Venture Investment, T1D Fund, ARCH Venture Partners, and Eli Lilly and Company Foundation are 5 of 7 investors who have invested in Jaguar Gene Therapy.

  • Who are Jaguar Gene Therapy’s competitors?

    Taysha Gene Therapies, ElevateBio, Sana Biotechnology, Spark Therapeutics, and Regenxbio are some of the 6 competitors of Jaguar Gene Therapy.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »